Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥ 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
ul 34 36 34 36 I-lower_bound

Alkaline 0 8 37 45 B-clinical_variable
phosphatase 9 20 46 57 I-clinical_variable
≤ 21 22 58 59 O
3X 23 25 60 62 B-upper_bound
the 26 29 63 66 I-upper_bound
institutional 30 43 67 80 I-upper_bound
ULN 44 47 81 84 I-upper_bound

Aspartate 0 9 85 94 B-clinical_variable
aminotransferase 10 26 95 111 I-clinical_variable
( 27 28 112 113 I-clinical_variable
AST)/alanine 28 40 113 125 I-clinical_variable
aminotransferase 41 57 126 142 I-clinical_variable
( 58 59 143 144 I-clinical_variable
ALT 59 62 144 147 I-clinical_variable
) 62 63 147 148 I-clinical_variable

M1 0 2 149 151 B-cancer
( 3 4 152 153 I-cancer
distant 4 11 153 160 I-cancer
metastasis 12 22 161 171 I-cancer
) 22 23 171 172 I-cancer
according 24 33 173 182 O
to 34 36 183 185 O
the 37 40 186 189 O
AJCC 41 45 190 194 O
2010 46 50 195 199 O
staging 51 58 200 207 O
system 59 65 208 214 O
will 66 70 215 219 O
be 71 73 220 222 O
ineligible 74 84 223 233 O

No 0 2 234 236 B-treatment
prior 3 8 237 242 I-treatment
chemotherapy 9 21 243 255 I-treatment
, 21 22 255 256 O
radiation 23 32 257 266 B-treatment
therapy 33 40 267 274 I-treatment
, 40 41 274 275 O
or 42 44 276 278 O
surgery 45 52 279 286 B-treatment
for 53 56 287 290 O
this 57 61 291 295 O
malignancy 62 72 296 306 B-cancer
will 73 77 307 311 O
be 78 80 312 314 O
allowed 81 88 315 322 O

Patients 0 8 323 331 O
must 9 13 332 336 O
have 14 18 337 341 O
a 19 20 342 343 O
histologic 21 31 344 354 O
diagnosis 32 41 355 364 O
of 42 44 365 367 O
adenocarcinoma 45 59 368 382 B-cancer
of 60 62 383 385 O
the 63 66 386 389 O
esophagus 67 76 390 399 O
, 76 77 399 400 O
GEJ 78 81 401 404 O

Patients 0 8 405 413 O
must 9 13 414 418 O
have 14 18 419 423 O
an 19 21 424 426 O
Eastern 22 29 427 434 B-clinical_variable
Cooperative 30 41 435 446 I-clinical_variable
Oncology 42 50 447 455 I-clinical_variable
Group 51 56 456 461 I-clinical_variable
( 57 58 462 463 I-clinical_variable
ECOG 58 62 463 467 I-clinical_variable
) 62 63 467 468 I-clinical_variable
performance 64 75 469 480 I-clinical_variable
status 76 82 481 487 I-clinical_variable
of 83 85 488 490 O
0 86 87 491 492 B-lower_bound
- 87 88 492 493 O
1 88 89 493 494 B-upper_bound

Patients 0 8 495 503 O
of 9 11 504 506 O
childbearing 12 24 507 519 O
potential 25 34 520 529 O
must 35 39 530 534 O
agree 40 45 535 540 O
to 46 48 541 543 O
use 49 52 544 547 B-contraception_consent
an 53 55 548 550 I-contraception_consent
effective 56 65 551 560 I-contraception_consent
form 66 70 561 565 I-contraception_consent
of 71 73 566 568 I-contraception_consent
contraception 74 87 569 582 I-contraception_consent
during 88 94 583 589 O
this 95 99 590 594 O
study 100 105 595 600 O

Patients 0 8 601 609 O
treated 9 16 610 617 O
with 17 21 618 622 O
brachytherapy 22 35 623 636 B-treatment
have 36 40 637 641 O
a 41 42 642 643 O
PSA 43 46 644 647 B-clinical_variable
within 47 53 648 654 O
the 54 57 655 658 O
institutional 58 71 659 672 O
normal 72 78 673 679 O
range 79 84 680 685 O

Patients 0 8 686 694 O
who 9 12 695 698 O
are 13 16 699 702 O
pregnant 17 25 703 711 B-pregnancy
or 26 28 712 714 O
lactating 29 38 715 724 O
will 39 43 725 729 O
not 44 47 730 733 O
be 48 50 734 736 O
eligible 51 59 737 745 O

Patients 0 8 746 754 O
who 9 12 755 758 O
are 13 16 759 762 O
receiving 17 26 763 772 O
any 27 30 773 776 O
other 31 36 777 782 O
concurrent 37 47 783 793 O
investigational 48 63 794 809 B-treatment
therapy 64 71 810 817 I-treatment
, 71 72 817 818 O
or 73 75 819 821 O
who 76 79 822 825 O
have 80 84 826 830 O
received 85 93 831 839 O
investigational 94 109 840 855 O
therapy 110 117 856 863 O
within 118 124 864 870 O
30 125 127 871 873 B-upper_bound
days 128 132 874 878 I-upper_bound
of 133 135 879 881 O
the 136 139 882 885 O
first 140 145 886 891 O
scheduled 146 155 892 901 O
day 156 159 902 905 O
of 160 162 906 908 O
protocol 163 171 909 917 B-treatment
treatment 172 181 918 927 I-treatment
( 182 183 928 929 O
investigational 183 198 929 944 O
therapy 199 206 945 952 O
as 207 209 953 955 O
defined 210 217 956 963 O
as 218 220 964 966 O
treatment 221 230 967 976 O
for 231 234 977 980 O
which 235 240 981 986 O
there 241 246 987 992 O
is 247 249 993 995 O
currently 250 259 996 1005 O
no 260 262 1006 1008 O
regulatory 263 273 1009 1019 O
authority 274 283 1020 1029 O
approved 284 292 1030 1038 O
indication 293 303 1039 1049 O
) 303 304 1049 1050 O
will 305 309 1051 1055 O
not 310 313 1056 1059 O
be 314 316 1060 1062 O
eligible 317 325 1063 1071 O

Patients 0 8 1072 1080 O
who 9 12 1081 1084 O
have 13 17 1085 1089 O
received 18 26 1090 1098 O
pelvic 27 33 1099 1105 B-treatment
external 34 42 1106 1114 I-treatment
beam 43 47 1115 1119 I-treatment
radiotherapy 48 60 1120 1132 I-treatment
are 61 64 1133 1136 O
not 65 68 1137 1140 O
eligible 69 77 1141 1149 O

Patients 0 8 1150 1158 O
with 9 13 1159 1163 O
Gilbert 14 21 1164 1171 B-chronic_disease
's 21 23 1171 1173 I-chronic_disease
syndrome 24 32 1174 1182 I-chronic_disease
are 33 36 1183 1186 O
eligible 37 45 1187 1195 O
provided 46 54 1196 1204 O
the 55 58 1205 1208 O
total 59 64 1209 1214 B-clinical_variable
bilirubin 65 74 1215 1224 I-clinical_variable
is 75 77 1225 1227 O
≤ 78 79 1228 1229 O
3 80 81 1230 1231 B-upper_bound

Patients 0 8 1232 1240 O
with 9 13 1241 1245 O
a 14 15 1246 1247 O
baseline 16 24 1248 1256 O
peripheral 25 35 1257 1267 B-clinical_variable
neuropathy 36 46 1268 1278 I-clinical_variable
≥ 47 48 1279 1280 O
grade 49 54 1281 1286 B-lower_bound
2 55 56 1287 1288 I-lower_bound
will 57 61 1289 1293 O
not 62 65 1294 1297 O
be 66 68 1298 1300 O
eligible 69 77 1301 1309 O

Patients 0 8 1310 1318 O
with 9 13 1319 1323 O
a 14 15 1324 1325 O
clinically 16 26 1326 1336 O
apparent 27 35 1337 1345 O
active 36 42 1346 1352 B-chronic_disease
infection 43 52 1353 1362 I-chronic_disease
will 53 57 1363 1367 O
not 58 61 1368 1371 O
be 62 64 1372 1374 O
eligible 65 73 1375 1383 O
( 74 75 1384 1385 O
please 75 81 1385 1391 O
note 82 86 1392 1396 O
, 86 87 1396 1397 O
an 88 90 1398 1400 O
isolated 91 99 1401 1409 O
elevation 100 109 1410 1419 O
in 110 112 1420 1422 O
the 113 116 1423 1426 O
white 117 122 1427 1432 O
blood 123 128 1433 1438 O
cell 129 133 1439 1443 O
count 134 139 1444 1449 O
, 139 140 1449 1450 O
by 141 143 1451 1453 O
itself 144 150 1454 1460 O
, 150 151 1460 1461 O
does 152 156 1462 1466 O
not 157 160 1467 1470 O
constitute 161 171 1471 1481 O
evidence 172 180 1482 1490 O
of 181 183 1491 1493 O
an 184 186 1494 1496 O
infection 187 196 1497 1506 O
) 196 197 1506 1507 O

Patients 0 8 1508 1516 O
with 9 13 1517 1521 O
a 14 15 1522 1523 O
known 16 21 1524 1529 O
history 22 29 1530 1537 O
of 30 32 1538 1540 O
infection 33 42 1541 1550 B-chronic_disease
with 43 47 1551 1555 O
hepatitis 48 57 1556 1565 B-chronic_disease
B 58 59 1566 1567 I-chronic_disease
or 60 62 1568 1570 O
hepatitis 63 72 1571 1580 B-chronic_disease
C 73 74 1581 1582 I-chronic_disease
virus 75 80 1583 1588 I-chronic_disease
( 81 82 1589 1590 O
active 82 88 1590 1596 O
, 88 89 1596 1597 O
previously 90 100 1598 1608 O
treated 101 108 1609 1616 O
, 108 109 1616 1617 O
or 110 112 1618 1620 O
both 113 117 1621 1625 O
) 117 118 1625 1626 O
will 119 123 1627 1631 O
not 124 127 1632 1635 O
be 128 130 1636 1638 O
eligible 131 139 1639 1647 O
due 140 143 1648 1651 O
to 144 146 1652 1654 O
the 147 150 1655 1658 O
increased 151 160 1659 1668 O
risk 161 165 1669 1673 O
of 166 168 1674 1676 O
hepatotoxicity 169 183 1677 1691 B-chronic_disease
and 184 187 1692 1695 O
viral 188 193 1696 1701 O
reactivation 194 206 1702 1714 O
associated 207 217 1715 1725 O
with 218 222 1726 1730 O
systemic 223 231 1731 1739 B-treatment
chemotherapy 232 244 1740 1752 I-treatment

Patients 0 8 1753 1761 O
with 9 13 1762 1766 O
angina 14 20 1767 1773 B-chronic_disease
, 20 21 1773 1774 O
a 22 23 1775 1776 O
cardiac 24 31 1777 1784 B-clinical_variable
ejection 32 40 1785 1793 I-clinical_variable
fraction 41 49 1794 1802 I-clinical_variable
< 50 51 1803 1804 O
50 52 54 1805 1807 B-upper_bound
% 54 55 1807 1808 I-upper_bound

Patients 0 8 1809 1817 O
with 9 13 1818 1822 O
any 14 17 1823 1826 O
history 18 25 1827 1834 O
of 26 28 1835 1837 O
solid 29 34 1838 1843 O
organ 35 40 1844 1849 O
or 41 43 1850 1852 O
bone 44 48 1853 1857 O
marrow 49 55 1858 1864 O
transplant 56 66 1865 1875 B-treatment
will 67 71 1876 1880 O
not 72 75 1881 1884 O
be 76 78 1885 1887 O
eligible 79 87 1888 1896 O

Patients 0 8 1897 1905 O
with 9 13 1906 1910 O
any 14 17 1911 1914 O
other 18 23 1915 1920 O
diagnosis 24 33 1921 1930 O
except 34 40 1931 1937 O
for 41 44 1938 1941 O
adenocarcinoma 45 59 1942 1956 B-cancer
( 60 61 1957 1958 O
squamous 61 69 1958 1966 B-cancer
cell 70 74 1967 1971 I-cancer
carcinoma 75 84 1972 1981 I-cancer
, 84 85 1981 1982 O
small 86 91 1983 1988 B-cancer
cell 92 96 1989 1993 I-cancer
carcinoma 97 106 1994 2003 I-cancer
, 106 107 2003 2004 O
mixed 108 113 2005 2010 B-cancer
adenosquamous 114 127 2011 2024 I-cancer
, 127 128 2024 2025 O
lymphoma 129 137 2026 2034 B-cancer
, 137 138 2034 2035 O
sarcoma 139 146 2036 2043 B-cancer
, 146 147 2043 2044 O
etc 148 151 2045 2048 O
. 151 152 2048 2049 O
) 152 153 2049 2050 O
will 154 158 2051 2055 O
be 159 161 2056 2058 O
ineligible 162 172 2059 2069 O

Patients 0 8 2070 2078 O
with 9 13 2079 2083 O
any 14 17 2084 2087 O
other 18 23 2088 2093 O
medical 24 31 2094 2101 B-chronic_disease
condition 32 41 2102 2111 I-chronic_disease
, 41 42 2111 2112 O
including 43 52 2113 2122 O
mental 53 59 2123 2129 B-treatment
illness 60 67 2130 2137 I-treatment
or 68 70 2138 2140 O
substance 71 80 2141 2150 O
abuse 81 86 2151 2156 O
, 86 87 2156 2157 O
deemed 88 94 2158 2164 O
by 95 97 2165 2167 O
the 98 101 2168 2171 O
investigator 102 114 2172 2184 O
to 115 117 2185 2187 O
be 118 120 2188 2190 O
likely 121 127 2191 2197 O
to 128 130 2198 2200 O
interfere 131 140 2201 2210 O
with 141 145 2211 2215 O
the 146 149 2216 2219 O
patient 150 157 2220 2227 O
's 157 159 2227 2229 O
ability 160 167 2230 2237 O
to 168 170 2238 2240 O
sign 171 175 2241 2245 O
informed 176 184 2246 2254 O
consent 185 192 2255 2262 O
, 192 193 2262 2263 O
cooperate 194 203 2264 2273 O
and 204 207 2274 2277 O
participate 208 219 2278 2289 O
in 220 222 2290 2292 O
the 223 226 2293 2296 O
study 227 232 2297 2302 O
, 232 233 2302 2303 O
or 234 236 2304 2306 O
interfere 237 246 2307 2316 O
with 247 251 2317 2321 O
the 252 255 2322 2325 O
interpretation 256 270 2326 2340 O
of 271 273 2341 2343 O
the 274 277 2344 2347 O
results 278 285 2348 2355 O
, 285 286 2355 2356 O
will 287 291 2357 2361 O
not 292 295 2362 2365 O
be 296 298 2366 2368 O
eligible 299 307 2369 2377 O

Patients 0 8 2378 2386 O
with 9 13 2387 2391 O
evidence 14 22 2392 2400 O
of 23 25 2401 2403 O
clinical 26 34 2404 2412 B-cancer
T4b 35 38 2413 2416 I-cancer
( 39 40 2417 2418 O
unresectable 40 52 2418 2430 O
) 52 53 2430 2431 O

Patients 0 8 2432 2440 O
with 9 13 2441 2445 O
known 14 19 2446 2451 O
hypersensitivity 20 36 2452 2468 B-treatment
to 37 39 2469 2471 O
any 40 43 2472 2475 O
component 44 53 2476 2485 O
of 54 56 2486 2488 O
the 57 60 2489 2492 O
chemotherapy 61 73 2493 2505 B-treatment
regimen 74 81 2506 2513 O
will 82 86 2514 2518 O
not 87 90 2519 2522 O
be 91 93 2523 2525 O
eligible 94 102 2526 2534 O

Patients 0 8 2535 2543 O
with 9 13 2544 2548 O
known 14 19 2549 2554 O
infection 20 29 2555 2564 B-chronic_disease
with 30 34 2565 2569 O
human 35 40 2570 2575 B-chronic_disease
immunodeficiency 41 57 2576 2592 I-chronic_disease
virus 58 63 2593 2598 I-chronic_disease
( 64 65 2599 2600 I-chronic_disease
HIV 65 68 2600 2603 I-chronic_disease
) 68 69 2603 2604 I-chronic_disease
will 70 74 2605 2609 O
not 75 78 2610 2613 O
be 79 81 2614 2616 O
eligible 82 90 2617 2625 O

Patients 0 8 2626 2634 O
with 9 13 2635 2639 O
localized 14 23 2640 2649 O
prostate 24 32 2650 2658 B-cancer
cancer 33 39 2659 2665 I-cancer
who 40 43 2666 2669 O
have 44 48 2670 2674 O
received 49 57 2675 2683 O
curative 58 66 2684 2692 O
intent 67 73 2693 2699 O
therapy 74 81 2700 2707 B-treatment
are 82 85 2708 2711 O
also 86 90 2712 2716 O
eligible 91 99 2717 2725 O
provided 100 108 2726 2734 O

Platelet 0 8 2735 2743 B-clinical_variable
count 9 14 2744 2749 I-clinical_variable
≥100,000 15 23 2750 2758 O
/ 23 24 2758 2759 I-lower_bound
ul 24 26 2759 2761 I-lower_bound

Resected 0 8 2762 2770 O
basal 9 14 2771 2776 B-cancer
cell 15 19 2777 2781 I-cancer
carcinoma 20 29 2782 2791 I-cancer
and 30 33 2792 2795 O
squamous 34 42 2796 2804 B-cancer
cell 43 47 2805 2809 I-cancer
carcinoma 48 57 2810 2819 I-cancer
of 58 60 2820 2822 I-cancer
the 61 64 2823 2826 I-cancer
skin 65 69 2827 2831 I-cancer
, 69 70 2831 2832 O
cervical 71 79 2833 2841 B-cancer
or 80 82 2842 2844 O
prostatic 83 92 2845 2854 B-cancer
intraepithelial 93 108 2855 2870 I-cancer
neoplasia 109 118 2871 2880 I-cancer
, 118 119 2880 2881 O
and 120 123 2882 2885 O
ductal 124 130 2886 2892 B-cancer
or 131 133 2893 2895 O
lobular 134 141 2896 2903 B-cancer
carcinoma 142 151 2904 2913 I-cancer
in 152 154 2914 2916 I-cancer
situ 155 159 2917 2921 I-cancer
of 160 162 2922 2924 I-cancer
the 163 166 2925 2928 I-cancer
breast 167 173 2929 2935 I-cancer

Serum 0 5 2936 2941 B-clinical_variable
creatinine 6 16 2942 2952 I-clinical_variable
( 17 18 2953 2954 I-clinical_variable
Scr 18 21 2954 2957 I-clinical_variable
) 21 22 2957 2958 I-clinical_variable
≤ 23 24 2959 2960 O
1.5mg 25 30 2961 2966 B-upper_bound
/ 30 31 2966 2967 I-upper_bound
dl 31 33 2967 2969 I-upper_bound

Serum 0 5 2970 2975 B-clinical_variable
total 6 11 2976 2981 I-clinical_variable
bilirubin 12 21 2982 2991 I-clinical_variable
≤ 22 23 2992 2993 O
1.5X 24 28 2994 2998 B-upper_bound
the 29 32 2999 3002 I-upper_bound
institutional 33 46 3003 3016 I-upper_bound
upper 47 52 3017 3022 I-upper_bound
limit 53 58 3023 3028 I-upper_bound
of 59 61 3029 3031 I-upper_bound
normal 62 68 3032 3038 I-upper_bound
( 69 70 3039 3040 I-upper_bound
ULN 70 73 3040 3043 I-upper_bound
) 73 74 3043 3044 I-upper_bound

Surgically 0 10 3045 3055 O
treated 11 18 3056 3063 O
patients 19 27 3064 3072 O
have 28 32 3073 3077 O
an 33 35 3078 3080 O
undetectable 36 48 3081 3093 O
prostate 49 57 3094 3102 B-clinical_variable
specific 58 66 3103 3111 I-clinical_variable
antigen 67 74 3112 3119 I-clinical_variable
( 75 76 3120 3121 I-clinical_variable
PSA 76 79 3121 3124 I-clinical_variable
) 79 80 3124 3125 I-clinical_variable

diffusing 0 9 3126 3135 B-clinical_variable
capacity 10 18 3136 3144 I-clinical_variable
of 19 21 3145 3147 I-clinical_variable
the 22 25 3148 3151 I-clinical_variable
lung 26 30 3152 3156 I-clinical_variable
for 31 34 3157 3160 I-clinical_variable
carbon 35 41 3161 3167 I-clinical_variable
monoxide 42 50 3168 3176 I-clinical_variable
( 51 52 3177 3178 I-clinical_variable
DLCO 52 56 3178 3182 I-clinical_variable
) 56 57 3182 3183 I-clinical_variable
> 58 59 3184 3185 O
50 60 62 3186 3188 B-lower_bound
% 62 63 3188 3189 I-lower_bound
predicted 64 73 3190 3199 O

for 0 3 3200 3203 O
90 4 6 3204 3206 B-upper_bound
days 7 11 3207 3211 I-upper_bound
following 12 21 3212 3221 O
the 22 25 3222 3225 O
last 26 30 3226 3230 O
dose 31 35 3231 3235 O
of 36 38 3236 3238 O
chemotherapy 39 51 3239 3251 B-treatment

ischemic 0 8 3252 3260 B-chronic_disease
heart 9 14 3261 3266 I-chronic_disease
disease 15 22 3267 3274 I-chronic_disease
are 23 26 3275 3278 O
not 27 30 3279 3282 O
eligible 31 39 3283 3291 O

must 0 4 3292 3296 O
have 5 9 3297 3301 O
either 10 16 3302 3308 O
clinical 17 25 3309 3317 O
T3 26 28 3318 3320 B-cancer
- 28 29 3320 3321 O
4a 29 31 3321 3323 B-cancer

pregnant 0 8 3324 3332 B-pregnancy
patients 9 17 3333 3341 O
are 18 21 3342 3345 O
ineligible 22 32 3346 3356 O

prior 0 5 3357 3362 B-treatment
endoscopic 6 16 3363 3373 I-treatment
procedures 17 27 3374 3384 I-treatment
for 28 31 3385 3388 O
superficial 32 43 3389 3400 O
disease 44 51 3401 3408 O
( 52 53 3409 3410 O
endoscopic 53 63 3410 3420 B-treatment
mucosal 64 71 3421 3428 I-treatment
resection 72 81 3429 3438 I-treatment
, 81 82 3438 3439 O
cryotherapy 83 94 3440 3451 B-treatment
, 94 95 3451 3452 O
photodynamic 96 108 3453 3465 B-treatment
therapy 109 116 3466 3473 I-treatment
, 116 117 3473 3474 O
etc 118 121 3475 3478 O
. 121 122 3478 3479 O
) 122 123 3479 3480 O
will 124 128 3481 3485 O
not 129 132 3486 3489 O
exclude 133 140 3490 3497 O
a 141 142 3498 3499 O
patient 143 150 3500 3507 O

staging 0 7 3508 3515 O
should 8 14 3516 3522 O
include 15 22 3523 3530 O
upper 23 28 3531 3536 B-treatment
endoscopy 29 38 3537 3546 I-treatment
with 39 43 3547 3551 I-treatment
endoscopic 44 54 3552 3562 I-treatment
ultrasound 55 65 3563 3573 I-treatment
and 66 69 3574 3577 O
a 70 71 3578 3579 O
fludeoxyglucose 72 87 3580 3595 B-treatment
( 88 89 3596 3597 I-treatment
FDG)-positron 89 102 3597 3610 I-treatment
emission 103 111 3611 3619 I-treatment
tomography 112 122 3620 3630 I-treatment
( 123 124 3631 3632 I-treatment
PET)/computed 124 137 3632 3645 I-treatment
tomography 138 148 3646 3656 I-treatment
( 149 150 3657 3658 I-treatment
CT 150 152 3658 3660 I-treatment
) 152 153 3660 3661 I-treatment
scan 154 158 3662 3666 I-treatment
( 159 160 3667 3668 O
with 160 164 3668 3672 O
diagnostic 165 175 3673 3683 O
CT 176 178 3684 3686 B-treatment
abdomen 179 186 3687 3694 I-treatment
/ 186 187 3694 3695 O
pelvis 187 193 3695 3701 B-treatment
preferred 194 203 3702 3711 O
) 203 204 3711 3712 O

the 0 3 3713 3716 O
remainder 4 13 3717 3726 O
of 14 16 3727 3729 O
the 17 20 3730 3733 O
liver 21 26 3734 3739 O
function 27 35 3740 3748 O
tests 36 41 3749 3754 O
( 42 43 3755 3756 O
ALT 43 46 3756 3759 B-clinical_variable
, 46 47 3759 3760 O
AST 48 51 3761 3764 B-clinical_variable
, 51 52 3764 3765 O
alkaline 53 61 3766 3774 B-clinical_variable
phosphatase 62 73 3775 3786 I-clinical_variable
[ 74 75 3787 3788 I-clinical_variable
ALK 75 78 3788 3791 I-clinical_variable
Phos 79 83 3792 3796 I-clinical_variable
] 83 84 3796 3797 I-clinical_variable
) 84 85 3797 3798 O
are 86 89 3799 3802 O
within 90 96 3803 3809 O
the 97 100 3810 3813 O
institutional 101 114 3814 3827 O
normal 115 121 3828 3834 O
range 122 127 3835 3840 O

tumors 0 6 3841 3847 B-cancer
of 7 9 3848 3850 I-cancer
the 10 13 3851 3854 I-cancer
GC 14 16 3855 3857 I-cancer
are 17 20 3858 3861 O
defined 21 28 3862 3869 O
as 29 31 3870 3872 O
originating 32 43 3873 3884 O
within 44 50 3885 3891 O
5 51 52 3892 3893 B-upper_bound
cm 53 55 3894 3896 I-upper_bound
of 56 58 3897 3899 O
the 59 62 3900 3903 O
GEJ 63 66 3904 3907 O

≤ 0 1 3908 3909 O
3X 2 4 3910 3912 B-upper_bound
the 5 8 3913 3916 I-upper_bound
institutional 9 22 3917 3930 I-upper_bound
ULN 23 26 3931 3934 I-upper_bound

≥ 0 1 3935 3936 O
N1 2 4 3937 3939 B-lower_bound
disease 5 12 3940 3947 O

